AXISCADES Technologies Ltd
AXISCADESAXISCADES Technologies Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the P/E sits at the 98th percentile of its own range — the multiple has already done part of the work.
The price is in a confirmed uptrend (88 weeks in) while the P/E sits at the 98th percentile of its own 11-year range. Underneath, the last four quarters read deteriorating — profit −171.4% year on year, and 92% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
AXISCADES Technologies Ltd trades at ₹1,832, in a confirmed uptrend and 88 weeks into that stage. That is +15.2% against its own 200-day average. It sits at 67% of a 52-week range of ₹1,124 to ₹2,174. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week.
Today the stock is in a confirmed uptrend — week 88 of stage 2, confirmed. At ₹1,832 it trades +15.2% versus its 200-day average and sits at 67% of its 52-week range (₹1,124–₹2,174).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +719% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 1 straight week — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
AXISCADES Technologies Ltd trades at 238.0× P/E, about the priciest it has ever traded. Its long-run median P/E is 33.1×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 238.0× is about the priciest it has ever traded, against a long-run median of 33.1× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved −4.0% against a +16.0% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the +91.5%/yr price move, ~+14.8%/yr came from earnings growth and ~+76.7 pp from the multiple (expanding); over 10y, of the +23.7%/yr price move, ~−3.1%/yr came from earnings growth and ~+26.8 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
AXISCADES Technologies Ltd reads as deteriorating on its fundamental arc. Deteriorating — profit and EPS growth are shrinking (profit growth −55.0% latest against +188.0% at its 12-quarter best), ROCE holding at 14.5%. The read is built from 12 quarters across 4 curves, on full evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −48.5% | −13.6% | +0.3% | +3.5% |
| Profit | −4.0% | — | — | +9.5% |
| EPS | −4.0% | — | — | +4.9% |
| Share price | +16.0% | +46.9% | +91.5% | +23.7% |
4-Factor Sector Score
33.1/100 — rank 21 of 25 in Aerospace & Defence - Equipments · 93% evidence confidence
AXISCADES Technologies Ltd scores 33.1 out of 100 against the 25 companies it is compared with in Aerospace & Defence - Equipments, ranking 21. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 11.9 + 3.9 + 10.9 + 6.4 = 33.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
AXISCADES Technologies Ltd reported ₹183 Cr of revenue in the Jun 26 quarter, +94.7% year on year. Over 10 years it has compounded at 3.5% a year. The last full year, FY26, came in at ₹531 Cr. The last four reported quarters add to ₹934 Cr.
FY26 revenue came in at ₹531 Cr (−48.5% on the year), capping 10 years at 3.5% compound. The latest quarter (Jun 26) printed ₹183 Cr, +94.7% year on year.
Pace check: the last four quarters averaged +18.2% growth against the decade's 3.5% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +3.5% over the last 4 quarters against −1.6%/yr over the last 8 — accelerating; TTM profit −55.0% vs −10.6%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
AXISCADES Technologies Ltd's operating margin is 4.7% in the Jun 26 quarter, −2.3 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 2.2% to 18.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 4.7%, −2.3 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 2.2%–18.0%.
🚨 Why the margin moved: operating margin went −2.5 pp year on year while gross margin went −12.7 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
AXISCADES Technologies Ltd posted a net loss of ₹15.0 Cr in the Jun 26 quarter. Full-year FY26 profit was ₹72.0 Cr. The 10-year compound rate is 9.5%. That loss is 8.2% of the quarter's revenue. The same quarter a year earlier earned ₹21.0 Cr. 1 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹−15.0 Cr, −171.4% year on year. On the full year, FY26 printed ₹72.0 Cr (−4.0%), and the 10-year compound rate is 9.5%.
🚨 Why profit moved: revenue contributed +94.7% and the margin −2.3 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −23.3% vs revenue +18.2%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 92% of AXISCADES Technologies Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹−1.0 Cr of operating cash against ₹72.0 Cr of profit. After ₹131 Cr of capital spending, ₹−132 Cr was left as free cash.
FY26: operating cash of ₹−1.0 Cr against reported profit of ₹72.0 Cr, leaving free cash of ₹−132 Cr after ₹131 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 92% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 92%: the cash cycle stretched 196 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 3.0× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
AXISCADES Technologies Ltd's cash conversion cycle runs 184 days in FY26, up from −12 days in FY21. Capital spending ran ₹299 Cr over the last 3 years. At FY26 sales of ₹531 Cr each day of that cycle holds about ₹1.5 Cr, so roughly ₹268 Cr sits inside the business at any moment.
FY26: debtors at 283 days, inventory at 121 days — roughly 4.0 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 184 days, looser than FY21's −12.
The full loop: cash goes out to suppliers and production on day 0; stock waits 121 days to sell; customers pay about 283 days after that; and suppliers themselves are paid at 221 days — netting out to the 184-day cycle.
In money terms: at FY26 sales of ₹531 Cr, each day of the cycle holds about ₹1.5 Cr — so the 184-day loop keeps roughly ₹268 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹299 Cr over the last 3 fiscal years against ₹99.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹44.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
AXISCADES Technologies Ltd earns a ROCE of 4% in FY26. That is up from a trough of 1% in FY19. Return on invested capital clears the cost of that capital by −4.6 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 13.6% net margin on 0.36× asset turns.
FY26 ROCE is 4%, recovered from a FY19 trough of 1% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 13.6% net margin × 0.36× asset turns × 2.02× balance-sheet leverage ≈ 9.9% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 7.4% − 12.0% = a −4.6 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
AXISCADES Technologies Ltd carries total debt of ₹388 Cr against shareholder equity of ₹734 Cr as of Mar 26, a debt-to-equity of 0.53. On the annual view that ratio went from 0.21 in FY22 to 0.53 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹388 Cr against shareholder equity of ₹734 Cr — a debt-to-equity of 0.53. On the annual view, debt-to-equity went from 0.21 (FY22) to 0.53 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Domestic institutions cut 2.6 points of AXISCADES Technologies Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 2.0% of the company. Promoters moved −2.2 points over the same window, to 58.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: −2.6 points over 8 quarters to 2.0%; Promoters: −2.2 points over 8 quarters to 58.0%; Foreign institutions: +1.1 points over 8 quarters to 1.4%.
🚨 Why the register moved: domestic institutions drove it (−2.6 points), alongside promoters (−2.2 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
AXISCADES Technologies Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Sigma Advanced System LtdSIGMAADV | 77.9/100Favorable setup82% evidence | LEADER | 28.4/35 Revenue 100% · PAT 20.3% · OPM change 307 pp 95% evidence | 17.2/25 ROCE 60.8% · OPM 16% 76% evidence | 12.5/20 P/E 95.1× · PEG — 50% evidence | 19.8/20 RS sector 113.1% · RS bench 161.3% · 1Y 481.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 28.4 + 17.2 + 12.5 + 19.8 = 77.9 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Paras Defence and Space Technologies LtdPARAS | 70.7/100Favorable setup82% evidence | LEADER | 25.8/35 Revenue 36.6% · PAT 54.8% · OPM change 2 pp 95% evidence | 17.1/25 ROCE 17.2% · OPM 25% 76% evidence | 9.0/20 P/E 125× · PEG — 50% evidence | 18.8/20 RS sector 29.1% · RS bench 66.5% · 1Y 117.2%12 of 12 weeks ahead 100% evidence |
| Exact sum: 25.8 + 17.1 + 9 + 18.8 = 70.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3MTAR Technologies LtdMTARTECH | 67.2/100Favorable setup90% evidence | TURNING | 30.4/35 Revenue 53.5% · PAT 100% · OPM change 6 pp 100% evidence | 15.3/25 ROCE 15.1% · OPM 24% 100% evidence | 8.0/20 P/E 165× · PEG — 50% evidence | 13.5/20 RS sector 29.8% · RS bench 63% · 1Y 419.4%5 of 12 weeks ahead 100% evidence |
| Exact sum: 30.4 + 15.3 + 8 + 13.5 = 67.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Azad Engineering LtdAZAD | 64.0/100Mixed-positive evidence93% evidence | LEADER | 24.2/35 Revenue 29% · PAT 41.4% · OPM change 1 pp 100% evidence | 12.8/25 ROCE 11.9% · OPM 37% 100% evidence | 8.2/20 P/E 132× · PEG 2.29 65% evidence | 18.8/20 RS sector 15.1% · RS bench 50.7% · 1Y 80.6%10 of 12 weeks ahead 100% evidence |
| Exact sum: 24.2 + 12.8 + 8.2 + 18.8 = 64 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Rossell Techsys LtdROSSTECH | 62.9/100Mixed-positive evidence83% evidence | BREAKING OUT | 28.8/35 Revenue 82.9% · PAT 68.8% · OPM change 1.8 pp 100% evidence | 8.0/25 ROCE 11.5% · OPM 14.4% 100% evidence | 8.9/20 P/E 173× · PEG — 15% evidence | 17.2/20 RS sector 13.1% · RS bench 48.2% · 1Y 69.8%8 of 12 weeks ahead 100% evidence |
| Exact sum: 28.8 + 8 + 8.9 + 17.2 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Sika Interplant Systems LtdSIKA | 62.4/100Mixed-positive evidence94% evidence | BREAKING OUT | 19.1/35 Revenue 0.5% · PAT 9.8% · OPM change 1.1 pp 100% evidence | 21.9/25 ROCE 34.6% · OPM 19.5% 100% evidence | 13.0/20 P/E 66.4× · PEG 1.01 100% evidence | 8.4/20 RS sector -10.2% · RS bench 7.8% · 1Y -4.3%8 of 9 weeks ahead 70% evidence |
| Exact sum: 19.1 + 21.9 + 13 + 8.4 = 62.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Vinyas Innovative Technologies LtdVINYAS | 60.0/100Thin evidence · provisional57% evidence | BREAKING OUT | 21.7/35 Revenue 65% · PAT 100% · OPM change 3 pp 48% evidence | 19.0/25 ROCE 21.4% · OPM 13% 95% evidence | 10.8/20 P/E 63.1× · PEG — 15% evidence | 8.5/20 RS sector -17.6% · RS bench 31.3% · 1Y 24.9%11 of 11 weeks ahead 70% evidence |
| Exact sum: 21.7 + 19 + 10.8 + 8.5 = 60 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Data Patterns (India) LtdDATAPATTNS | 58.3/100Mixed-positive evidence100% evidence | LEADER | 22.8/35 Revenue 33.9% · PAT 24.2% · OPM change -5 pp 100% evidence | 19.8/25 ROCE 21.9% · OPM 27% 100% evidence | 3.0/20 P/E 100× · PEG 3.94 100% evidence | 12.7/20 RS sector 7.7% · RS bench 40.5% · 1Y 95%10 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 19.8 + 3 + 12.7 = 58.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 9Jaykay Enterprises LtdJAYKAY | 54.3/100Mixed-positive evidence74% evidence | ASLEEP | 29.0/35 Revenue 100% · PAT 100% · OPM change 1.8 pp 95% evidence | 8.1/25 ROCE 8.2% · OPM 14.2% 95% evidence | 11.1/20 P/E 61.2× · PEG — 15% evidence | 6.1/20 RS sector -20.9% · RS bench 1.6% · 1Y 13.3%1 of 10 weeks ahead 70% evidence |
| Exact sum: 29 + 8.1 + 11.1 + 6.1 = 54.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.9% and the one-year return is 13.3%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 10Astra Microwave Products LtdASTRAMICRO | 53.5/100Mixed-positive evidence100% evidence | LEADER | 16.0/35 Revenue 3.9% · PAT 17.4% · OPM change -1 pp 100% evidence | 17.7/25 ROCE 20.3% · OPM 19% 100% evidence | 4.8/20 P/E 84.4× · PEG 3.3 100% evidence | 15.0/20 RS sector 7.8% · RS bench 39.8% · 1Y 66.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 16 + 17.7 + 4.8 + 15 = 53.5 · Decision use: Price leads the evidence: RS versus the benchmark is 39.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 11Hindustan Aeronautics LtdHAL | 52.3/100Mixed-positive evidence100% evidence | BREAKING OUT | 13.9/35 Revenue 7.4% · PAT 12.2% · OPM change 1 pp 100% evidence | 20.4/25 ROCE 32% · OPM 28% 100% evidence | 8.2/20 P/E 35.2× · PEG 3.54 100% evidence | 9.8/20 RS sector -17.1% · RS bench 11.6% · 1Y 11.4%8 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 20.4 + 8.2 + 9.8 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Apollo Micro Systems LtdAPOLLO | 51.8/100Mixed-positive evidence100% evidence | FADING | 19.6/35 Revenue 68.8% · PAT 74.2% · OPM change -10 pp 100% evidence | 13.4/25 ROCE 14.5% · OPM 21% 100% evidence | 7.2/20 P/E 129× · PEG 1.6 100% evidence | 11.6/20 RS sector 6.4% · RS bench 38.8% · 1Y 38.6%8 of 12 weeks ahead 100% evidence |
| Exact sum: 19.6 + 13.4 + 7.2 + 11.6 = 51.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Dynamatic Technologies LtdDYNAMATECH | 48.5/100Mixed-negative evidence83% evidence | TURNING | 18.3/35 Revenue 17.3% · PAT 0% · OPM change 3 pp 100% evidence | 9.3/25 ROCE 10.2% · OPM 13% 100% evidence | 9.2/20 P/E 140× · PEG — 15% evidence | 11.7/20 RS sector -6.1% · RS bench 25% · 1Y 82.9%3 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 9.3 + 9.2 + 11.7 = 48.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Mishra Dhatu Nigam LtdMIDHANI | 45.5/100Mixed-negative evidence100% evidence | TURNING | 16.6/35 Revenue 18.2% · PAT 13.4% · OPM change -5 pp 100% evidence | 11.5/25 ROCE 11.3% · OPM 15% 100% evidence | 7.5/20 P/E 62.1× · PEG 5.62 100% evidence | 9.9/20 RS sector -9.5% · RS bench 20.5% · 1Y 18.7%4 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 11.5 + 7.5 + 9.9 = 45.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Bharat Electronics LtdBEL | 45.0/100Mixed-negative evidence100% evidence | TURNING | 14.7/35 Revenue 19.8% · PAT 11.8% · OPM change -3 pp 100% evidence | 19.3/25 ROCE 36.4% · OPM 25% 100% evidence | 7.5/20 P/E 48.1× · PEG 3.54 100% evidence | 3.5/20 RS sector -27.8% · RS bench -2.2% · 1Y 9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.7 + 19.3 + 7.5 + 3.5 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Ideaforge Technology LtdIDEAFORGE | 44.5/100Mixed-negative evidence74% evidence | ASLEEP | 26.7/35 Revenue 100% · PAT 100% · OPM change 152.7 pp 74% evidence | 1.3/25 ROCE -2.8% · OPM 3.4% 100% evidence | 8.5/20 P/E 928× · PEG — 15% evidence | 8.0/20 RS sector -3.5% · RS bench 24.1% · 1Y 44.1%7 of 12 weeks ahead 100% evidence |
| Exact sum: 26.7 + 1.3 + 8.5 + 8 = 44.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17High Energy Batteries (India) Ltd504176 | 43.3/100Mixed-negative evidence67% evidence | TURNING | 6.7/35 Revenue 1.5% · PAT -3.5% · OPM change -32.1 pp 95% evidence | 14.2/25 ROCE 20.4% · OPM -26.5% 76% evidence | 12.3/20 P/E 38.9× · PEG — 50% evidence | 10.1/20 RS sector — · RS bench 4.7% · 1Y —4 of 4 weeks ahead 25% evidence |
| Exact sum: 6.7 + 14.2 + 12.3 + 10.1 = 43.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Zen Technologies LtdZENTEC | 41.4/100Mixed-negative evidence69% evidence | FADING | 5.1/35 Revenue -23.4% · PAT -27.8% · OPM change -14 pp 95% evidence | 16.7/25 ROCE 16.2% · OPM 27% 76% evidence | 10.2/20 P/E 85.6× · PEG — 15% evidence | 9.4/20 RS sector -6.6% · RS bench 13.1% · 1Y 16.5%5 of 10 weeks ahead 70% evidence |
| Exact sum: 5.1 + 16.7 + 10.2 + 9.4 = 41.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19BEML LtdBEML | 40.5/100Mixed-negative evidence91% evidence | BREAKING OUT | 15.9/35 Revenue 12.8% · PAT -40.1% · OPM change 8.2 pp 74% evidence | 3.5/25 ROCE 7.7% · OPM 0.2% 100% evidence | 10.7/20 P/E 94.4× · PEG 1.18 100% evidence | 10.4/20 RS sector -17% · RS bench 12% · 1Y -0.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 15.9 + 3.5 + 10.7 + 10.4 = 40.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Bharat Dynamics LtdBDL | 35.2/100Mixed-negative evidence93% evidence | TURNING | 12.1/35 Revenue -18.7% · PAT -7.1% · OPM change 33 pp 100% evidence | 13.3/25 ROCE 13.8% · OPM 15% 100% evidence | 5.9/20 P/E 83.8× · PEG 4.44 65% evidence | 3.9/20 RS sector -35.7% · RS bench -12.4% · 1Y -17.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 12.1 + 13.3 + 5.9 + 3.9 = 35.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21AXISCADES Technologies Ltdthis pageAXISCADES | 33.1/100Adverse evidence93% evidence | ASLEEP | 11.9/35 Revenue 3.5% · PAT -55% · OPM change -2.3 pp 100% evidence | 3.9/25 ROCE 3.6% · OPM 4.7% 100% evidence | 10.9/20 P/E 238× · PEG 1.39 65% evidence | 6.4/20 RS sector -12% · RS bench 17% · 1Y 27.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 11.9 + 3.9 + 10.9 + 6.4 = 33.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Avantel LtdAVANTEL | 32.1/100Adverse evidence83% evidence | ASLEEP | 9.9/35 Revenue -3.2% · PAT -67.2% · OPM change 4.6 pp 100% evidence | 10.2/25 ROCE 9.6% · OPM 24.8% 100% evidence | 8.6/20 P/E 242× · PEG — 15% evidence | 3.4/20 RS sector -26.5% · RS bench -1.1% · 1Y -11.6%4 of 12 weeks ahead 100% evidence |
| Exact sum: 9.9 + 10.2 + 8.6 + 3.4 = 32.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23NIBE LtdNIBE | 24.1/100Adverse evidence66% evidence | FADING | 3.0/35 Revenue -5.2% · PAT -80% · OPM change -24 pp 95% evidence | 5.4/25 ROCE 4.8% · OPM -15% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.7/20 RS sector -29.8% · RS bench 4.7% · 1Y 7.1%7 of 11 weeks ahead 70% evidence |
| Exact sum: 3 + 5.4 + 10 + 5.7 = 24.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24DCX Systems LtdDCXINDIA | 24.0/100Adverse evidence71% evidence | BASING | 5.9/35 Revenue -46.5% · PAT -80% · OPM change -10.9 pp 95% evidence | 4.2/25 ROCE 0.9% · OPM -10.4% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.9/20 RS sector -27.1% · RS bench -12.3% · 1Y -37.9%1 of 10 weeks ahead 70% evidence |
| Exact sum: 5.9 + 4.2 + 10 + 3.9 = 24 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Aequs LtdAEQUS | 39.1/100Thin evidence · provisional35% evidence | BREAKING OUT | 14.9/35 Revenue — · PAT — · OPM change -7.3 pp 45% evidence | 4.2/25 ROCE 1.7% · OPM 3.7% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —12 of 12 weeks ahead 0% evidence |
| Exact sum: 14.9 + 4.2 + 10 + 10 = 39.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is AXISCADES Technologies Ltd's share price today?
AXISCADES Technologies Ltd trades at ₹1,832, +16.0% over the past year. The company is valued at ₹7,791 Cr. The stock sits at 67% of its 52-week range of ₹1,124–₹2,174, +15.2% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 88 weeks in. — as of 11 September 2026.
What were AXISCADES Technologies Ltd's latest quarterly results?
AXISCADES Technologies Ltd reported revenue of ₹183 Cr and a net loss of ₹15.0 Cr for the Jun 26 quarter. Revenue rose 94.7% and profit fell 171.4% year on year. Earnings per share were ₹−3.49. The operating margin was 4.7%, 2.3 pp lower than a year earlier. — as of 11 September 2026.
What is AXISCADES Technologies Ltd's revenue?
AXISCADES Technologies Ltd reported revenue of ₹183 Cr in the Jun 26 quarter, +94.7% year on year. For the full FY26 fiscal year, revenue was ₹531 Cr (−48.5%). Over the last 10 years revenue compounded at 3.5% a year. — as of 11 September 2026.
What is AXISCADES Technologies Ltd's profit?
AXISCADES Technologies Ltd earned ₹−15.0 Cr of net profit in the Jun 26 quarter, −171.4% year on year. Full-year FY26 profit was ₹72.0 Cr. The operating margin ran 4.7% in the latest quarter. — as of 11 September 2026.
What is AXISCADES Technologies Ltd's market cap?
AXISCADES Technologies Ltd's market capitalisation is ₹7,791 Cr at a share price of ₹1,832. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is AXISCADES Technologies Ltd's P/E ratio?
AXISCADES Technologies Ltd trades at a P/E of 238.0×, at the 98th percentile of its own 11-year range, against a long-run median of 33.1×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does AXISCADES Technologies Ltd pay a dividend?
No — AXISCADES Technologies Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 11 September 2026.
Is AXISCADES Technologies Ltd overvalued?
On its own history, AXISCADES Technologies Ltd looks expensive: its P/E of 238.0× sits at the 98th percentile of its 11-year range (long-run median 33.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is AXISCADES Technologies Ltd growing?
Not right now — AXISCADES Technologies Ltd's latest numbers are shrinking: latest-quarter revenue +94.7% year on year, profit −171.4%, and the margin −2.3 pp at 4.7%. The 10-year compound rates are 3.5% (revenue) and 9.5% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.
How is AXISCADES Technologies Ltd performing?
AXISCADES Technologies Ltd is in a confirmed uptrend, 88 weeks in. Its latest quarter's revenue rose 94.7% and profit fell 171.4% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is AXISCADES Technologies Ltd in?
Deteriorating — profit and EPS growth are shrinking (profit growth −55.0% latest against +188.0% at its 12-quarter best), ROCE holding at 14.5%. The read comes from the last 12 quarters of growth (revenue growth +3.5% latest, profit growth −55.0% latest, eps growth −53.8% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is AXISCADES Technologies Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 88 of stage 2), trading +15.2% versus its 200-day average and at 67% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is AXISCADES Technologies Ltd beating the market?
On recent form, yes — AXISCADES Technologies Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +719% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.
Will AXISCADES Technologies Ltd's share price go up?
This page publishes no price forecast for AXISCADES Technologies Ltd. What it measures instead: the share price is ₹1,832, the price is in a confirmed uptrend 88 weeks in. Its P/E of 238.0× sits at the 98th percentile of its own 11-year range. — as of 11 September 2026.
Who owns AXISCADES Technologies Ltd?
Promoters hold 58.0% of AXISCADES Technologies Ltd, foreign institutions 1.4%, domestic institutions 2.0% and the public 38.6% (latest quarter). The biggest move on the register over the last two years: Domestic institutions cut 2.6 points over 8 quarters. — as of 11 September 2026.
Does AXISCADES Technologies Ltd have too much debt?
It is moderate — AXISCADES Technologies Ltd's debt-to-equity is 0.53, and operating profit covers the interest bill 2×. FY26 borrowings were ₹388 Cr against equity of ₹727 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is AXISCADES Technologies Ltd's capex?
AXISCADES Technologies Ltd spent ₹299 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹131 Cr, with ₹44.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is AXISCADES Technologies Ltd's cash flow?
AXISCADES Technologies Ltd consumed ₹1.0 Cr of operating cash in FY26 — cash flowed out rather than in (free cash flow: ₹−132 Cr). Operating cash was negative while the company reported a profit of ₹72.0 Cr. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is AXISCADES Technologies Ltd's profit real cash?
Yes — over the last 3 fiscal years, 92% of AXISCADES Technologies Ltd's reported profit arrived as operating cash. Though the latest year ran at -1% — the trend is the thing to watch. In FY26, operating cash was ₹−1.0 Cr against reported profit of ₹72.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is AXISCADES Technologies Ltd in its business cycle?
AXISCADES Technologies Ltd's FY26 operating margin was 9.0%, against a 13-year band of 2.2%–18.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 4.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What could break the AXISCADES Technologies Ltd story?
Biggest watch item: the P/E sits at the 98th percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is AXISCADES Technologies Ltd a stock worth studying right now?
This is not investment advice. The machine read: AXISCADES Technologies Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!